Key result
Surgical explantation of infected transcatheter aortic valve prostheses was associated with an overall postoperative in-hospital mortality of 28%.
Why the study?
Survival of patients with an infected TAVI prosthesis is generally poor, but only a minority (10%) have undergone surgical explantation.
Systematic Review (n=107)
Answers are grounded in this paper and cite their sources.
Surgical explantation of infected TAVI prostheses is associated with a 28% in-hospital mortality, which may represent a viable life-saving option for a highly lethal condition.
There is growing interest in infections occurring after transcatheter aortic valve implantation (TAVI). The incidence, and clinical and anatomical features suggest many similarities with prosthetic valve endocarditis. The survival of patients with an infected TAVI prosthesis is generally poor; however, only a minority of them (10%) have undergone treatment with surgical explantation of the infected prosthesis. A literature search was performed using online databases. Papers reporting surgical treatment of TAVI prosthesis infections were retrieved, focusing on pre- and intraoperative characteristics and early outcome. Thirty-seven papers ultimately provided information on 107 patients. Their mean ± standard deviation (SD) age was 76 ± 8 years and 72% were male. The mean ± SD time interval between the TAVI procedure and reoperation was 10 ± 10 months. Annular abscess formation was described in 34% of cases and mitral valve involvement in 31%. All patients underwent TAVI prosthesis explantation and surgical aortic valve replacement; concomitant mitral valve replacement was necessary in 22% of cases. Postoperative in-hospital mortality was 28%. Surgical explantation of infected TAVI prostheses was associated with a high postoperative mortality, although these initial experiences included elderly and high-risk patients. Considering the expansion of TAVI procedures towards younger and lower-risk patients, surgical treatment of TAVI endocarditis may represent the best option for a life-saving procedure.
No takes yet. Share an insight, caveat, or question.
Malvindi et al. (2020) conducted a systematic review in Transcatheter aortic valve infective endocarditis (n=107). Surgical explantation of TAVI prosthesis was evaluated on Postoperative in-hospital mortality. Surgical explantation of infected transcatheter aortic valve prostheses was associated with an overall postoperative in-hospital mortality of 28%.
Synapse has enriched 10 related papers. Consider them for comparative context: